170 related articles for article (PubMed ID: 32857655)
21. Comparing clinical trial population representativeness to real-world populations: an external validity analysis encompassing 43 895 trials and 5 685 738 individuals across 989 unique drugs and 286 conditions in England.
Tan YY; Papez V; Chang WH; Mueller SH; Denaxas S; Lai AG
Lancet Healthy Longev; 2022 Oct; 3(10):e674-e689. PubMed ID: 36150402
[TBL] [Abstract][Full Text] [Related]
22. Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data.
Pauly NJ; Talbert JC; Brown J
J Manag Care Spec Pharm; 2016 Jun; 22(6):741-51. PubMed ID: 27231801
[TBL] [Abstract][Full Text] [Related]
23. Stroke, multimorbidity and polypharmacy in a nationally representative sample of 1,424,378 patients in Scotland: implications for treatment burden.
Gallacher KI; Batty GD; McLean G; Mercer SW; Guthrie B; May CR; Langhorne P; Mair FS
BMC Med; 2014 Oct; 12():151. PubMed ID: 25280748
[TBL] [Abstract][Full Text] [Related]
24. Prevalence, Patterns, and Cost of Care for Children with Cerebral Palsy Enrolled in Medicaid Managed Care.
Pulgar S; Bains S; Gooch J; Chambers H; Noritz GH; Wright E; Sawhney TG; Pyenson B; Ferro C
J Manag Care Spec Pharm; 2019 Jul; 25(7):817-822. PubMed ID: 31232210
[TBL] [Abstract][Full Text] [Related]
25. Economic burden of paediatric-onset disabilities among young and middle-aged adults in the USA: a cohort study of privately insured beneficiaries.
Whitney D; Kamdar N; Hirth RA; Hurvitz EA; Peterson MD
BMJ Open; 2019 Sep; 9(9):e030490. PubMed ID: 31481565
[TBL] [Abstract][Full Text] [Related]
26. Childhood neurodevelopmental disorders and maternal hypertensive disorder of pregnancy.
Chen KR; Yu T; Kang L; Lien YJ; Kuo PL
Dev Med Child Neurol; 2021 Sep; 63(9):1107-1113. PubMed ID: 33884610
[TBL] [Abstract][Full Text] [Related]
27. Opioid prescription patterns among commercially insured children with and without cerebral palsy.
Ayoubi L; Pruente J; Daunter AK; Erickson SR; Whibley D; Whitney DG
J Pediatr Rehabil Med; 2024; 17(1):47-56. PubMed ID: 38489199
[TBL] [Abstract][Full Text] [Related]
28. Patient factors associated with new prescribing of potentially inappropriate medications in multimorbid US older adults using multiple medications.
Jungo KT; Streit S; Lauffenburger JC
BMC Geriatr; 2021 Mar; 21(1):163. PubMed ID: 33676398
[TBL] [Abstract][Full Text] [Related]
29. Whitney Comorbidity Index to monitor health status for adults with cerebral palsy: validation and thresholds to assist clinical decision making.
Whitney DG; Basu T
Dev Med Child Neurol; 2021 Jul; 63(7):853-859. PubMed ID: 33829504
[TBL] [Abstract][Full Text] [Related]
30. Effect of pain on mood affective disorders in adults with cerebral palsy.
Whitney DG; Bell S; Whibley D; Van der Slot WMA; Hurvitz EA; Haapala HJ; Peterson MD; Warschausky SA
Dev Med Child Neurol; 2020 Aug; 62(8):926-932. PubMed ID: 32388867
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of high-burden medical conditions and health care resource utilization and costs among adults with cerebral palsy.
Whitney DG; Kamdar NS; Ng S; Hurvitz EA; Peterson MD
Clin Epidemiol; 2019; 11():469-481. PubMed ID: 31417318
[No Abstract] [Full Text] [Related]
32. Comorbidity Clusters Among Adults With Cerebral Palsy: A Latent Class Analysis.
Leis AM; Hurvitz EA; Whitney DG
Am J Prev Med; 2024 Jun; 66(6):971-979. PubMed ID: 38278372
[TBL] [Abstract][Full Text] [Related]
33. Risk of Depression and Anxiety in Adults With Cerebral Palsy.
Smith KJ; Peterson MD; O'Connell NE; Victor C; Liverani S; Anokye N; Ryan JM
JAMA Neurol; 2019 Mar; 76(3):294-300. PubMed ID: 30592485
[TBL] [Abstract][Full Text] [Related]
34. Factors associated with polypharmacy and the prescription of multiple medications among persons living with HIV (PLWH) compared to non-PLWH.
Moore HN; Mao L; Oramasionwu CU
AIDS Care; 2015; 27(12):1443-8. PubMed ID: 26608408
[TBL] [Abstract][Full Text] [Related]
35. Post-fracture pneumonia risk and association with health and survival outcomes for adults with cerebral palsy: A retrospective cohort study.
Whitney DG; Xu T; Berri M
Bone; 2022 Jun; 159():116390. PubMed ID: 35307581
[TBL] [Abstract][Full Text] [Related]
36. Burden of multimorbidity and polypharmacy among cancer survivors: a population-based nested case-control study.
Keats MR; Cui Y; DeClercq V; Grandy SA; Sweeney E; Dummer TJB
Support Care Cancer; 2021 Feb; 29(2):713-723. PubMed ID: 32444894
[TBL] [Abstract][Full Text] [Related]
37. Characterization of Chronic Multiclass Psychotropic Polypharmacy and Psychotherapy in Foster Care Youth in a State Medicaid Population.
Keast SL; Tidmore LM; Shropshire D; Nesser N; Lambert TL
J Manag Care Spec Pharm; 2019 Dec; 25(12):1340-1348. PubMed ID: 31778625
[TBL] [Abstract][Full Text] [Related]
38. Exercise interventions for cerebral palsy.
Ryan JM; Cassidy EE; Noorduyn SG; O'Connell NE
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011660. PubMed ID: 28602046
[TBL] [Abstract][Full Text] [Related]
39. Data linkage and pain medication in people with cerebral palsy: a cross-sectional study.
Garca Jalon EG; Maguire A; Perra O; Gavin A; O'Reilly D; Thurston A
Dev Med Child Neurol; 2021 Sep; 63(9):1085-1092. PubMed ID: 33786820
[TBL] [Abstract][Full Text] [Related]
40. Noncommunicable disease and multimorbidity in young adults with cerebral palsy.
Whitney DG; Hurvitz EA; Ryan JM; Devlin MJ; Caird MS; French ZP; Ellenberg EC; Peterson MD
Clin Epidemiol; 2018; 10():511-519. PubMed ID: 29750055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
